Influence of metabolic genotype GSTM1 on levels of urinary mutagens in patients treated topically with coal tar

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 440, Issue 1, 1999, Pages 27-33

  Gabbani, G ^a   Pavanello, S ^a   Nardini, B ^a   Tognato, O ^a   Bordin, A ^a   Fornasa, C Veller ^a   Bezze, G ^a   Clonfero, E ^a  

^a NONE

Author keywords

Ames test; Coal tar treatment; GSTM1; Metabolic genotype; Polycyclic aromatic hydrocarbon (PAH); Urinary mutagen; YG1024

Indexed keywords

COAL TAR; POLYCYCLIC AROMATIC HYDROCARBON;

ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; GENOTYPE; HUMAN; MUTAGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN DISEASE; TECHNIQUE; TOPICAL DRUG ADMINISTRATION; URINALYSIS;

ADMINISTRATION, TOPICAL; COAL TAR; DNA; DNA PRIMERS; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LEUKOCYTES, MONONUCLEAR; MICROSOMES, LIVER; MUTAGENICITY TESTS; MUTAGENS; OINTMENTS; POLYCYCLIC HYDROCARBONS, AROMATIC; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PYRENES; SALMONELLA TYPHIMURIUM; SKIN DISEASES;

BACTERIA (MICROORGANISMS); SALMONELLA TYPHIMURIUM; TYPHIMURIUM;

EID: 0033060363     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(99)00013-3     Document Type: Article

References (31)

1. International Agency for Research on Cancer. Overall evaluation of carcinogenicity: An Updating of IARC Monographs, Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, IARC (Ed.), Vols. 1-42, Suppl. 7, Lyon, 1987.
2. Wheeler L.A., Saperstein M.D., Lowe N.J. Mutagenicity of urine from psoriatic patients undergoing treatment with coal tar and ultraviolet light. J. Invest. Dermatol. 77:1981;181-185.
3. Clonfero E., Zordan M., Cottica D., Venier P., Pozzoli L., Cardin E.L., Sarto F., Levis A.G. Mutagenic activity and polycyclic aromatic hydrocarbon levels in urine of humans exposed to therapeutical coal tar. Carcinogenesis. 7:1986;819-823.
4. Clonfero E., Zordan M., Venier P., Paleologo M., Levis A.G., Cottica D., Pozzoli L., Jongeneelen F.J., Bos R.P., Anzion R.B.M. Biological monitoring of human exposure to coal tar. Int. Arch. Occup. Environ. Health. 61:1989;363-368.
5. Santella R.M., Nunes M.G., Blaskovic R., Perera F.P., Tang D., Beachman A., Lin J.H., Deleo V.A. Quantitation of polycyclic aromatic hydrocarbons, 1-hydroxypyrene, and mutagenicity in urine of coal tar-treated psoriasis patients and untreated volunteers. Cancer Epidemiol., Biomarkers and Prev. 3:1994;137-140.
6. Göen T., Gundel J., Schaller K., Angerer J. The elimination of 1-hydroxypyrene in the urine of the general population and workers with different occupational exposures to PAH. Sci. Total Environ. 163:1995;195-201.
7. Levin J.O. First international workshop on hydroxypyrene as a biomarker for PAH exposure in man - summary and conclusions. Sci. Total Environ. 163:1995;165-168.
8. Hayes J.D., Pulford D.J. The glutathione S-transferase supergene family: regulation of GST* and the contribution of the isoezymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol. 30:1995;445-600.
9. Ketterer B. Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis. Mutation Res. 202:1988;343-361.
10. Ketterer B., Harris J.M., Talaska G., Meyer D.J., Pemble S.E., Taylor J.B., Lang N.P., Kadlubar F.F. The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer. Environ. Health Perspect. 98:1992;87-94.
11. Seidegård J., Pero R.W., Markowitz M.M., Roush G., Beattie E.J. Isoenzyme(s) of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer: a follow-up study. Carcinogenesis. 11:1990;33-36.
12. Awasthi Y.C., Sharma R., Singhal S.S. Human glutathione S-transferases. Int. J. Biochem. 26:1994;295-308.
13. Bell D.A., Taylor J.A., Paulson D.F., Robertson C.N., Mohler J.L., Lucier G.W. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl. Cancer Inst. 85:1993;1159-1164.
14. McWilliams J.E., Sanderson B.J.S., Harris E.L., Richer-Boe K.E., Henner W.D. Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol., Biomarkers and Prev. 4:1995;589-594.
15. Brockmöller J., Cascorbi I., Kerb R., Roots I. Combined analysis of inherited polymorphisms in arylamine N-acetyltranferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res. 56:1996;3915-3925.
16. D'Errico A., Taioli E., Chen X., Vineis P. Genetic metabolic polymorphisms and the risk of cancer: a review of the literature. Biomarkers. 1:1996;149-173.
17. Binkovà B., Lewtas J., Mìskova I., Rössner P., Cernà M., Mràckova G., Peterkovà K., Mumford Y., Meyer S., Šrám R. Biomarker studies in Northern Bohemia. Environ. Health Perspect. 104:1996;591-597. Suppl. 3.
18. Hirvonen A., Nylund L., Kociba P., Husgafvel-Pursiainen K., Vainio H. Modulation of urinary mutagenicity by genetically determined metabolism in smokers. Carcinogenesis. 15:1994;813-815.
19. Gabbani G., Hou S.-H., Nardini B., Marchioro M., Lambert B., Clonfero E. GSTM1 and NAT2 genotypes and urinary mutagens in coke oven workers. Carcinogenesis. 17:1996;1677-1681.
20. Jongeneelen F.J., Anzion R.B.M., Scheepers P.T.J., Bos R.B., Henderson P.Th., Nijenhuis E.H., Veenstra S.J., Brouns R.M.E., Winkes A. 1-Hydroxypyrene in urine as a biological indicator of exposure to polycyclic aromatic hydrocarbons in several work environments. Ann. Occup. Hyg. 32:1988;35-43.
21. Hou S.-H., Lambert B., Hemminki K. Relationship between hprt mutant frequency, aromatic DNA adducts and genotypes for GSTM1 and NAT2 in bus maintenance workers. Carcinogenesis. 16:1995;1913-1917.
22. Jongeneelen F.J., Anzion R.B.M., Henderson P.Th. Determination of hydroxylated metabolites of polycyclic aromatic hydrocarbons in urine. J. Chromatogr. 413:1987;227-232.
23. Yamasaki E., Ames B.N. Concentration of mutagens from urine by absorption with the non-polar resin XAD-2: cigarette smokers have mutagenic urine. Proc. Natl. Acad. Sci. USA. 74:1977;3555-3559.
24. Maron D., Ames B.N. Revised methods for the Salmonella test. Mutation Res. 113:1983;173-215.
25. Watanabe M., Ishidate M. Jr., Nohmi T. Sensitive method for the detection of mutagenic nitroarenes and aromatic amines: new derivatives of Salmonella typhimurium tester strains possessing elevated O-acetyltransferase levels. Mutation Res. 234:1990;337-348.
26. Clonfero E., Granella M., Marchioro M., Leopardi Barra E., Nardini B., Ferri G., Foà V. Urinary excretion of mutagens in coke oven workers. Carcinogenesis. 16:1995;547-554.
27. Granella M., Clonfero E. Sensitivity of different bacterial assays in detecting mutagens in urine of humans exposed to polycyclic aromatic hydrocarbons. Mutation Res. 268:1992;131-137.
28. Einistö P., Nohmi T., Watanabe M., Ishidate M. Jr. Sensitivity of Salmonella typhimurium YG1024 to urine mutagenicity caused by cigarette smoking. Mutation Res. 245:1990;87-92.
29. Gabbani G., Nardini B., Bordin A., Pavanello S., Janni L., Celotti L., Clonfero E. Urinary mutagenicity on TA98 and YG10224 Salmonella typhimurium strains after a hamburger meal: influence of GSTM1 and NAT2 genotypes. Mutagenesis. 13:1998;187-191.
30. Schimid M.-H., Korting H.C. Coal tar, pine tar and sulfonated shale oil preparations: comparative activity, efficacy and safety. Dermatology. 193:1996;1-5.
31. Van Schooten F.-J., Godschalk R. Coal tar therapy: is it carcinogenic? Drug Safety. 15:1996;374-377.